158 related articles for article (PubMed ID: 38142529)
1. Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases.
Ji J; Liu T; Yao Y; Liu W; Ning H; Wang T; Zhang G
Neoplasia; 2024 Jan; 47():100961. PubMed ID: 38142529
[TBL] [Abstract][Full Text] [Related]
2. Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy.
Chen J; Miranda G; Cai J; Daneshmand S; Djaladat H
Scand J Urol; 2019; 53(2-3):123-128. PubMed ID: 31081431
[No Abstract] [Full Text] [Related]
3. Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.
Supit W; Mochtar CA; Santoso RB; Umbas R
Asian J Surg; 2014 Oct; 37(4):184-9. PubMed ID: 24637186
[TBL] [Abstract][Full Text] [Related]
4. Prostate Specific Antigen Nadir After Radical Cystoprostatectomy in Patients With Benign Prostatic Tissue: A Benchmark To Define Biochemical Recurrence after Radical Prostatectomy.
Hosseini SY; Alemi M; Amini E; Riazi N
Urol J; 2019 Dec; 16(6):563-566. PubMed ID: 31004342
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.
Zargar H; Shah JB; van Rhijn BW; Daneshmand S; Bivalacqua TJ; Spiess PE; Black PC; Kassouf W;
J Urol; 2018 Jun; 199(6):1452-1458. PubMed ID: 29329894
[TBL] [Abstract][Full Text] [Related]
6. Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy.
Hajiran A; Azizi M; Aydin AM; Zemp L; Peyton CC; Dhillon J; Nealon S; Reich RR; Cao B; Li R; Manley BJ; Sexton WJ; Gilbert SM
J Urol; 2021 Jan; 205(1):100-108. PubMed ID: 32783489
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593
[TBL] [Abstract][Full Text] [Related]
8. Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.
Linder BJ; Frank I; Cheville JC; Thompson RH; Thapa P; Tarrell RF; Boorjian SA
J Urol; 2013 May; 189(5):1670-5. PubMed ID: 23142686
[TBL] [Abstract][Full Text] [Related]
9. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
Kaushik D; Frank I; Boorjian SA; Cheville JC; Eisenberg MS; Thapa P; Tarrell RF; Thompson RH
Int J Urol; 2015 Jun; 22(6):549-54. PubMed ID: 25761779
[TBL] [Abstract][Full Text] [Related]
11. Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer.
Luchey AM; Lin HY; Yue B; Agarwal G; Gilbert SM; Lockhart J; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
J Urol; 2015 Nov; 194(5):1220-5. PubMed ID: 26055823
[TBL] [Abstract][Full Text] [Related]
12. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.
Knoedler JJ; Boorjian SA; Tollefson MK; Cheville JC; Thapa P; Tarrell RF; Frank I
BJU Int; 2014 Dec; 114(6):832-6. PubMed ID: 24119219
[TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid urothelial bladder carcinoma in adults: Histology, symptomatology, treatments and survival.
Sabaté Arroyo XA; Rodrigo Lara H; Carrillo García P; Brugarolas Rosselló J; Pizá Reus P
Actas Urol Esp (Engl Ed); 2019 Mar; 43(2):106-110. PubMed ID: 30287139
[TBL] [Abstract][Full Text] [Related]
14. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience.
Vallancien G; Abou El Fettouh H; Cathelineau X; Baumert H; Fromont G; Guillonneau B
J Urol; 2002 Dec; 168(6):2413-7. PubMed ID: 12441929
[TBL] [Abstract][Full Text] [Related]
15. T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy.
De Berardinis E; Busetto GM; Antonini G; Giovannone R; Gentile V
Int Urol Nephrol; 2011 Dec; 43(4):1047-57. PubMed ID: 21442469
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
17. Outcome of urinary bladder cancer after combined therapies.
Anghel RM; Gales LN; Trifanescu OG
J Med Life; 2016; 9(2):153-9. PubMed ID: 27453746
[TBL] [Abstract][Full Text] [Related]
18. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
Fairey AS; Daneshmand S; Wang L; Schuckman A; Lieskovsky G; Djaladat H; Cai J; Miranda G; Skinner EC
Urol Oncol; 2014 Feb; 32(2):110-6. PubMed ID: 23499168
[TBL] [Abstract][Full Text] [Related]
19. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases.
Njinou Ngninkeu B; Lorge F; Moulin P; Jamart J; Van Cangh PJ
J Urol; 2003 Jan; 169(1):149-52. PubMed ID: 12478124
[TBL] [Abstract][Full Text] [Related]
20. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
